[Triple fungal infection in a patient with liver cirrhosis]

Ann Biol Clin (Paris). 2012 Jan-Feb;70(1):89-92. doi: 10.1684/abc.2011.0654.
[Article in French]

Abstract

The prevalence of invasive mycoses is increasing, especially among patients who are immunocompromised or hospitalized with serious underlying diseases. Such infections are associated with a high morbidity and significant mortality, requiring early diagnosis and appropriate treatment but also an optimal prophylaxis in patients with high risk factors. We report a case of triple fungal infection including an invasive pulmonary aspergillosis by Aspergillus fumigatus, a candidemia by Candida albicans and a Pneumocystis pneumonia. The overall clinical picture of this patient was liver cirrhosis with medical history of immunosuppressive treatment for Crohn disease and a non-hodgkin lymphoma. There was no antifungal prophylaxis for this patient. Under treatment, the issue was unfavourable with multivisceral failure.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aspergillosis / chemically induced
  • Aspergillosis / complications
  • Aspergillosis / diagnosis
  • Candidiasis / chemically induced
  • Candidiasis / complications
  • Candidiasis / diagnosis
  • Fatal Outcome
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects
  • Liver Cirrhosis / chemically induced
  • Liver Cirrhosis / complications*
  • Male
  • Middle Aged
  • Multiple Organ Failure
  • Mycoses / chemically induced
  • Mycoses / complications*
  • Mycoses / diagnosis
  • Pneumonia, Pneumocystis / chemically induced
  • Pneumonia, Pneumocystis / complications
  • Pneumonia, Pneumocystis / diagnosis

Substances

  • Immunosuppressive Agents